ENvue Medical Inc FEED
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
ENvue Medical Provides Nasdaq Listing Update
-
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
-
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
-
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
-
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
-
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
Trading Information
- Previous Close Price
- $0.35
- Day Range
- $0.28–0.37
- 52-Week Range
- $0.20–73.08
- Bid/Ask
- — / —
- Shares Outstanding
- 923,718.00
- Market Cap
- $339,049.22
- Volume/Avg
- 1,172 / 81,043
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.05
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. It focuses on two technology platforms: the ENvue Navigation Platform, which provides an electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract; FDA 510(k) cleared for adult use, it provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Its Medical advances non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation in healthcare environments, and the company's acoustic-based therapeutic technologies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 14
- Website
- https://www.envuemed.com
Valuation
|
Metric
|
FEED
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.01 |
Price/Sales | 0.05 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FEED
|
|---|---|
Quick Ratio | 0.22 |
Current Ratio | 0.66 |
Interest Coverage | — |
Quick Ratio
FEED
Profitability
|
Metric
|
FEED
|
|---|---|
Return on Assets (Normalized) | −31.84% |
Return on Equity (Normalized) | −40.02% |
Return on Invested Capital (Normalized) | −51.40% |
Return on Assets
FEED
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|&f?!W<y | LOCK|%c#P | $177B | |||
| Medtronic PLC
MDT
| LOCK|Yw#L$bw | LOCK|x&?p> | $124B | |||
| Stryker Corp
SYK
| LOCK|m#>%^mC | LOCK|vH | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|@h@dMZ^ | LOCK|@DgRN | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|@>^nX@>% | LOCK|rdBZ | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|V%!%F?% | LOCK|CMJ | $32B | |||
| DexCom Inc
DXCM
| LOCK|^rX%^&WM | LOCK|c<mn | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Mf | LOCK|%qG | $26B | |||
| Steris PLC
STE
| LOCK|B?^%&&Z | LOCK|Cd>b? | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|?QV#@z% | LOCK|XBx | $19B |
United States